Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories
Autoři
FIEGL, M.; M. ERDEL; I. TINHOFER; G. HOPFINGER; K. EIGENBERGER; F. FALKNER; A. FALKNER; Y. BRYCHTOVÁ; A. PANOVSKÁ; Michael DOUBEK; A. ZABERNIGG; S. SODIA; H. MÜHLBERGER; C. FONATSCH; G. GASTL; Jiří MAYER a R. GREIL
FIEGL, M.; M. ERDEL; I. TINHOFER; G. HOPFINGER; K. EIGENBERGER; F. FALKNER; A. FALKNER; Y. BRYCHTOVÁ; A. PANOVSKÁ; Michael DOUBEK; A. ZABERNIGG; S. SODIA; H. MÜHLBERGER; C. FONATSCH; G. GASTL; Jiří MAYER a R. GREIL. Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories. Blood. 2008, roč. 112, č. 11, s. 1085-1085.
@article{822035, author = {Fiegl, M. and Erdel, M. and Tinhofer, I. and Hopfinger, G. and Eigenberger, K. and Falkner, F. and Falkner, A. and Brychtová, Y. and Panovská, A. and Doubek, Michael and Zabernigg, A. and Sodia, S. and Mühlberger, H. and Fonatsch, C. and Gastl, G. and Mayer, Jiří and Greil, R.}, article_number = {11}, journal = {Blood}, title = {Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories}, volume = {112}, year = {2008} }
TY - JOUR ID - 822035 AU - Fiegl, M. - Erdel, M. - Tinhofer, I. - Hopfinger, G. - Eigenberger, K. - Falkner, F. - Falkner, A. - Brychtová, Y. - Panovská, A. - Doubek, Michael - Zabernigg, A. - Sodia, S. - Mühlberger, H. - Fonatsch, C. - Gastl, G. - Mayer, Jiří - Greil, R. PY - 2008 TI - Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories JF - Blood VL - 112 IS - 11 SP - 1085-1085 EP - 1085-1085 ER -
FIEGL, M.; M. ERDEL; I. TINHOFER; G. HOPFINGER; K. EIGENBERGER; F. FALKNER; A. FALKNER; Y. BRYCHTOVÁ; A. PANOVSKÁ; Michael DOUBEK; A. ZABERNIGG; S. SODIA; H. MÜHLBERGER; C. FONATSCH; G. GASTL; Jiří MAYER a R. GREIL. Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories. \textit{Blood}. 2008, roč.~112, č.~11, s.~1085-1085.